Abstract
Due to its high prevalence and diversity of its forms, chronic neocancer pain is noted to have become a serious medical problem. Chronic pain is regarded as an independent disease, not a symptom of any disease, which calls for special attention and complex etiopathogenetic treatment. The paper gives the characteristics and causes of pain syndromes and an algorithm for the treatment of chronic pain. It is stated that treating patients with chronic neocancer pain requires that its clinical features be kept in mind; moreover, treatment should be itself safe and effective. Drugs must be used for a long period, by strictly following the schedule in individual doses.
Highlights
По данным Европейского эпидемиологического исследования, частота хронических неонкологических болевых синдромов в странах Западной Европы составляет 20%, т. е. каждый 5-й взрослый европеец страдает хроническим болевым синдромом [1]
It is stated that treating patients with chronic neocancer pain requires that its clinical features be kept in mind; treatment should be itself safe and effective
При ноцицептивной и психогенной боли функционально-структурные изменения в системе болевой чувствительности проявляются сенситизацией периферических и центральных ноцицептивных нейронов, в результате которой повышается эффективность синаптической передачи и возникает стойкая гипервозбудимость ноцицептивных нейронов
Summary
По данным Европейского эпидемиологического исследования, частота хронических неонкологических болевых синдромов в странах Западной Европы составляет 20%, т. е. каждый 5-й взрослый европеец страдает хроническим болевым синдромом [1]. 6. Rosales R.L., Chua-Yap A.S. Evidence-based systematic review on the efficacy and safety of botulinum toxin-A therapy in post-stroke spasticity. 7. Simpson D.M., Gracies J.-M., Graham H.K. et al Assessment: Botulinum toxin for the treatment of spasticity (an evidence-based review): Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
